OP22.04: Non-Invasive Prenatal Testing (NIPT) for 22q11.2 Deletion Syndrome Using a Targeted Microarray-Based Cell-Free DNA (cfDNA) Test

Ultrasound in Obstetrics and Gynecology - United States
doi 10.1002/uog.17901
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Non-Invasive Prenatal Testing for Hemoglobin Bart’s Hydrops Fetalis Syndrome (SEA Deletion) Using Cell-Free Fetal DNA in Maternal Plasma: Systematic Review and Meta-Analysis

International Journal of Human Genetics
Genetics
2018English

Presymptomatic Detection of Metastatic Breast Cancer Using Non-Invasive Prenatal Testing (NIPT)

Pathology
Forensic MedicinePathology
2020English

Validation of a SNP-based Non-Invasive Prenatal Test to Detect the Fetal 22q11.2 Deletion in Maternal Plasma Samples

PLoS ONE
Multidisciplinary
2018English

Cell-Free Fetal DNA and Non-Invasive Prenatal Diagnosis

British Journal of General Practice
MedicineFamily Practice
2009English

EP07.08: Clinical Experience With Non-Invasive Prenatal Testing (NIPT) for Rare Autosomal Trisomies

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2018English

Genome-Wide Cell-Free DNA Based Non-Invasive Prenatal Testing Identifies Trisomy 14 Mosaicism in Association With Uniparental Disomy

Pathology
Forensic MedicinePathology
2020English

Noninvasive Prenatal Testing From Cell-Free DNA

CMAJ
Medicine
2014English

An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population

PLoS ONE
Multidisciplinary
2015English

Antenatal Screening for Fetal Trisomies Using Microarray‐based Cell‐free DNA Testing – A Systematic Review and Meta‐analysis

Prenatal Diagnosis
GynecologyGeneticsObstetrics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy